Related content

Inhaled Corticosteroids With/Without Long-Acting -Agonists Reduce the Risk of Rehospitalization and Death in COPD Patients

By Soriano J.B.  

American Journal of Respiratory Medicine, Vol. 2, Iss. 1, 2003-01 ,pp. : 67-74

Adis International

Access to resources Recommend Favorite

Addition of Transdermal or Inhaled Long-Acting β 2-Agonists in Adult Asthmatic Patients Treated with Inhaled Corticosteroids: Switchover Study from Tulobuterol Patch to Salmeterol Dry Powder Inhaler

By Kobayashi Yoshiki   Yasuba Hirotaka   Kudou Megumi   Kita Hideo  

Journal of Asthma, Vol. 44, Iss. 2, 2007-03 ,pp. : 77-81

Informa Healthcare

Access to resources Recommend Favorite

Combination Inhalers Containing Inhaled Corticosteroids and Long-Acting β 2 -Agonists: Improved Clinical Efficacy and Dosing Options in Patients with Asthma

By Ankerst Jaro  

Journal of Asthma, Vol. 42, Iss. 9, 2005-10 ,pp. : 715-724

Informa Healthcare

Access to resources Recommend Favorite

Clinical Safety of Long-Acting β 2 -Agonist and Inhaled Corticosteroid Combination Therapy in COPD

By Decramer Marc   Ferguson Gary  

COPD: Journal of Chronic Obstructive Pulmonary Disease, Vol. 3, Iss. 3, 2006-09 ,pp. : 163-171

Informa Healthcare

Access to resources Recommend Favorite

Tolerability Profiles of Leukotriene Receptor Antagonists and Long-Acting β2-Adrenoceptor Agonists in Combination with Inhaled Corticosteroids for Treatment of Asthma: A Review

By Colucci R.   Fornai M.   Tuccori M.   Antonioli L.   Pasqualetti G.   Blandizzi C.   Tacca M. Del  

Journal of Asthma, Vol. 44, Iss. 6, 2007-07 ,pp. : 411-422

Informa Healthcare

Access to resources Recommend Favorite